BioCentury
ARTICLE | Clinical News

Elan to begin Phase IIa

July 23, 2001 7:00 AM UTC

ELN and partner American Home Products (AHP) will begin this quarter a 375-patient Phase IIa study of AN-1792 beta amyloid 42-amino acid peptide vaccine to treat mild-to-moderate Alzheimer's disease (...